The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

US FDA approves Azurity Pharma’s Xifyrm for management of moderate-to-severe pain in adults: Woburn, Massachusetts Thursday, June 12, 2025, 12:00 Hrs [IST] Azurity Pharmaceutica ...

NSAIDs may cause some side effects. NSAIDs come under the wider definition of non-opioid analgesics. Doctors typically use NSAIDs rather than opioid pain relievers, such as morphine, to treat less ...

Suggested strategies for analgesic/anti-inflammatory treatment ... on GI risk Intermediate (1–3% per year) tNSAID (low-dose ibuprofen or naproxen + PPI); if aspirin is indicated, naproxen ...

Delivered as a once-daily 30 mg/mL IV bolus injection over 15 seconds, Xifyrm can be used alone or alongside non-NSAID ...

A new oral analgesic without the health risks associated ... “Existing treatments such as opioids, acetaminophen, and NSAIDs pose risks of addiction and toxicity with overuse.” ...

Many NSAIDs and other analgesics are available in topical form, like creams or patches, and can offer similar relief without the potential side effects to your gut. There are also nonmedication ...

Introduction: Non-steroidal anti-inflammatory drugs (NSAID) are commonly used in sports medicine. NSAID have known anti-inflammatory, analgesic, antipyretic and antithrombotic effects, although their ...

In osteoarthritis, studies have shown that acetaminophen may have efficacy, although more people find NSAIDs to be effective. Thus, the use of nonnarcotic analgesics may be effective in those ...

Use of over-the-counter (OTC) analgesics — including acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) — improves concussion symptoms and reduces recovery time in injured ...

NSAIDs, ketamine, and mid- to high-potency ... For a "comprehensive comparison of the safety and efficacy of the available analgesics to inform clinical guidelines and practice," the group ...